4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Apoptosis Modelling for Treatment Decisions in Colorectal Cancer (APO-DECIDE)
Date du début: 1 nov. 2012, Date de fin: 31 oct. 2014,
"With the arrival of new colorectal cancer (CRC) therapeutics targeting specific cell signalling pathways, such as anti-EGFR therapy, personalised cancer treatment is at the door step of clinical practise. This progress in drug development contrasts strikingly with current clinical practice, where decision making depends largely on clinical factors such as tumour staging and age of patient, with t ...
Voir le projet
7
Participants partenaires
TERMINÉ
Virtual Integrated Partnering (VIP) for SME service, technology and information providers in the European maritime sector (EuroVIP)
Date du début: 1 juin 2011, Date de fin: 31 mai 2014,
EuroVIP aims to co-ordinate European maritime SMEs, associations, larger companies, and research institutions to promote the application of research results and innovative technologies in SMEs, by service, technology and information (STI) transfer in terms of operational and technical collaboration support. It will provide a viable and sustainable means for the exploitation of outputs from past, p ...
Voir le projet
21
Participants partenaires
TERMINÉ
"OXY-SENSE - A biosensor, image analysis, and work flow system platform for the study of neuronal injury and assessment of cellular bioenergetics" (OXY-SENSE)
Date du début: 1 août 2009, Date de fin: 31 juil. 2013,
"Cellular bioenergetics play a key role in the pathogenesis of acute and chronic neurological disorders. Novel sensors and analytical systems in combination with biomedical imaging can provide powerful new insights into the role of cellular bioenergetics in the propagation of disease states. OXY-SENSE is an Industry-Academia partnership of experienced neuroscientists, experts in optical oxygen sen ...
Voir le projet
4
Participants partenaires
TERMINÉ
The Diabetic Brain
Date du début: 1 oct. 2010, Date de fin: 30 sept. 2012,
Type 2 diabetes is one of the most common chronic diseases in the world, and the number of those affected has been raising dramatically in recent years. In type 2 diabetes the body fails to use insulin effectively, which leads to the chronic increase in blood glucose that characterises the disease. It is not known why the body becomes resistant to insulin but evidence suggests that an imbalance be ...
Voir le projet